vimarsana.com
Home
Live Updates
dsm-firmenich secures 3-FL HMO market access in Europe : vimarsana.com
dsm-firmenich secures 3-FL HMO market access in Europe
dsm-firmenich has secured European market access for its 3-fucosyllactose (3-FL) ingredient, one of the most abundant human milk oligosaccharides (HMO) in human milk.
Related Keywords
Marta Miks ,
Panel On Nutrition ,
Regulatory Affairs ,
European Food Safety Authority ,
European Commission ,
Senior Regulatory Scientific Affairs ,
Novel Food ,
Scientific Opinion ,
Novel Foods ,
Food Allergens ,
Senior Regulatory ,
Scientific Affairs Manager ,
Suppliers ,
Supplements ,
Infant Amp Maternal ,
Airy Based Ingredients ,
Probiotics ,
Rebiotics Amp Postbiotics ,
Ut Digestive Health ,
Immune Support ,
Aternal Amp Infant Health ,
Imo ,
Regulation ,
vimarsana.com © 2020. All Rights Reserved.